Most tumors affecting the extrahepatic bile duct are adenocarcinomas; the other histologic types occur only rarely. We herein report the extremely rare case of signet ring cell carcinoma (SRCC) originating from the extrahepatic bile duct. A 55-year-old man was hospitalized for jaundice and pruritus. Computed tomography and positron emission tomography suggested the presence of distal extrahepatic bile-duct cancer. He underwent a pylorus preserving pancreaticoduodenectomy. A histologic study confirmed a signet ring cell neoplasm of the distal common bile duct. Because the upper resection margin was invaded by the tumor, he received postoperative concurrent chemoradiotherapy and four cycles of chemotherapy. The patient has survived with no evidence of recurrence for 2 years. This is the second case of primary SRCC of the distal extrahepatic bile duct reported in the literature; further reports of cases are warranted to determine the nature of SRCC in the extrahepatic bile duct. (Gut Liver 2010;4:402-406)
INTRODUCTION
Most cholangiocarcinomas involve the perihilar and distal extrhepatic bile ducts. About two thirds are perihilar tumors, about one fourth are distal extrahepatic tumors, and the others are intrahepatic tumors.
1,2 Cholangiocarcinomas are usually adenocarcinomas. Other less common histologic variants are papillary carcinoma and mucinous carcinoma. And the rare conditions, which occur in less than 5 percent of cases, include squamous-cell carcinoma, small-cell carcinoma, and mesenchymal tumors. 3 Signet ring cell carcinoma (SRCC) is commonly found in the stomach and there is only one reported case of signet ring cell carcinoma in the extrahepatic bile duct. 4 We herein report a case of 55-year-old man with SRCC in the extrahepatic bile duct.
CASE REPORT
A 55-year-old male was hospitalized for jaundice and pruritus. Upon physical examination, he presented with icteric sclera and visible jaundice. Blood chemistry tests showed total bilirubin 4.5 mg/dL, aspartate aminotransferase (AST) 19 IU/L, alanine aminotransferase (ALT) 105 IU/L, alkaline phosphatase (ALP) 453 IU/L, γ-glutamyltransferase (GGT) 380 IU/L, and lipase 97 U/L. The serum electrolytes, urea nitrogen, and creatinine were normal. Tumor marker, carbohydrate antigen (CA) 19-9 was slightly elevated up to 45.9 U/mL. Computed tomography (CT) showed a hypervascular mass at the distal common bile duct and ampulla of Vater ( Figs. 1 and 2 ). The intrahepatic bile duct and extrahepatic bile duct were proportionally dilated. Positron emission tomography (PET) showed increased 18 fluoro-2-deoxyglucose (FDG) uptake in the distal extrahepatic bile duct and the others were not remarkable (Fig. 3) . Biopsy samples from the ampulla of Vater by endoscopic retrograde cholangioscope (Fig. 4) showed metastatic SRCC because there were tumor cells only in lamina propria and no transitional zone in biopsy samples from the ampulla of Vater. Samples from the distal extrahepatic bile duct showed no malignancy due to insufficient material. The endoscopic retrograde cholangiography revealed the protruded and engorged ampulla of Vater. The common bile duct and intrahepatic bile duct were markedly dilated. There was complete obstruction at the distal common bile duct. To decompress the biliary system, an endoscopic retrograde biliary drainage tube was inserted (Fig. 5 ).
Esophagogastroduodenoscope and colonoscope for evaluation of the common primary site of signet ring cell carcinoma did not show any abnormality.
The patient underwent a pylorus preserving pancreaticoduodenectomy (PPPD) with extended lymph node dissection including paraarotic lymph nodes. On gross evaluation of the resected specimen, the wall of the common bile duct was thickened predominantly at the distal part measuring up to 1 cm. The cut surface of the thickened common bile duct wall showed concentric fibrosis and intervening gray tan areas (Fig. 6) . The lesion was connected to the duodenal muscle and pancreatic parenchyma. A few gray colored myxoid nodules were noted in the perimuscular connective tissue of the common bile duct. The ampulla of Vater was not prominant, grossly. The proximal part of common bile duct was slightly dilated. The cystic duct, gallbladder, and duodenal mucosa were grossly unremarkable (Fig. 7) .
The histology of the main tumor mass revealed SRCC (Figs. 8 and 9 ) invading perimuscular soft tissue and involving pancreatic parenchyma, ampulla of Vater, duodenal submucosa, and myenteric plexus. Extensive neural invasion and mucin pool formation were also detected. The tumor cells were found in a ruptured peripancreatic node. And tumor cells were noted on the proximal resection margin of common bile duct. With these histologic finidings, the patient was confirmed to T3N1M0, stage IIB signet ring cell carcinoma of the distal common bile duct with R1 resection status.
He was taken postoperative concurrent chemoradiotherapy with total radiation dose of 50.4 Gray on the tumor bed. The combination of gemcitabine and cisplatin was used for chemotherapeutic regimen of concurrent chemoradiotherapy. After that, he underwent additional 4 cycles of gemcitabine and cisplatin chemotherapy until now without any evidence of recurrence.
DISCUSSION
The incidence of bile duct tumors in large autopsy studies varies from 0.01% to 0.2%, and may constitute about 2% of all reported cancer. 1, 3 Tumors of the distal extrahepatic bile duct represent approximately 20% to 30% of all bile duct cancers and 5% to 10% of all periampullary tumors. 1, 5 The majority of patients are over 65 years of age, and the peak incidence occurs in the seventh decade of life.
5
SRCC of the biliary system is extremely rare and most SRCCs of the biliary system are originated from gallbladder. Currently, only one case of SRCC from the lower bile duct has been reported in the English literature. 4 And this case is the second case of primary signet ring cell carcinoma of the distal extrahepatic bile duct reported in literature. Commonly, bile duct cancer spreads longitudinally along the bile duct wall and connective tissue. It can go through the submucosa in spite of intact epithelial lining. Because the extent of ductal tumor spread is difficult to know preoperatively, the intraopertive frozen section analysis is important to determine the degree of submucosal spreading and to spare tumor-free resection margin. 3, 6, 7 Wakai et al. 8 suggested that ductal margin status was a strong independent prognostic factor and invasive ductal carcinoma at resection margin appeared to have a strong adverse effect on patient survival. In this case, resection margin was clear in intraoperative frozen section analysis, but proximal resection margin was invaded by tumor in final pathologic report. It has long been suggested that extrahepatic bile duct tumors progress slowly. 9 However, progression can be rapid in some patients. In general, SRCCs of other digestive organs progress rapidly and have a poor prognosis. [10] [11] [12] Hiraki et al. 4 reported one case of extrahepatic SRCC of rapid growth and aggressive nature. It is unclear whether the progression is more rapid in patients with SRCCs than patients with other type tumors because of extreme rarity. In this case, the patient is still alive without visible remnant lesion after surgery and chemoradiotherapy. The origin of SRCCs in periampullary area is not known well. There are two possible explanations for this histologic variation. One explanation is that the tumors may arise from ectopic gastric mucosa. Indeed, there are some reported cases of SRCCs with ectopic gastric mucosa in ampullary tumors. Another explanation suggests that SRCCs may develop from gastric-type epithelial metaplasia. The presence of duodenal ulcer and elevated intraluminal acidity may irritate epithelial lining and can induce gastric-type metaplasia. It can be etiology of the periampullary SRCCs. [12] [13] [14] At the present case, no ectopic gastric mucosa and epithelial metaplasia was found in surgical specimen of the duodenum. The patients also did not have a previous history of peptic ulcer disease. In this case, we could make differential diagnosis between the distal common bile duct cancer and the ampulla of Vater cancer, as there were transitional zone from mural gland to signet ring cell carcinoma in distal portion of the common bile duct.
In conclusion, curative therapy may be possible with surgery and adjuvant therapy in SRCC of distal extrahepatic bile duct. But due to extreme rarity of this disease, additional case reports are warranted to decide the nature and optimal management of the disease.
